MARKET

MKKGY

MKKGY

Merck Kgaa
OTCPK
31.07
-0.23
-0.73%
Closed 15:49 04/18 EDT
OPEN
30.99
PREV CLOSE
31.30
HIGH
31.19
LOW
30.91
VOLUME
9.57K
TURNOVER
297.56K
52 WEEK HIGH
52.29
52 WEEK LOW
28.79
MARKET CAP
20.08B
P/E (TTM)
21.67
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MKKGY last week (0408-0412)?
Weekly Report · 3d ago
908 Devices: Rare Early-Stage Bioprocess Investment Opportunity
908 Devices, Inc. Is a company focused on mass spectrometry and bioprocessing 4.0. The company has three main platforms for growth in the forensic industry. Life science tools are essential for the growth of the healthcare industry. 908 Devices is a rare early-stage investment opportunity in the life science tools industry.
Seeking Alpha · 04/10 16:49
Weekly Report: what happened at MKKGY last week (0401-0405)?
Weekly Report · 04/08 12:34
Weekly Report: what happened at MKKGY last week (0325-0329)?
Weekly Report · 04/01 12:29
Weekly Report: what happened at MKKGY last week (0318-0322)?
Weekly Report · 03/25 12:33
Week In Review: 3 Multinationals Plan Investments In Southeast Asia Facilities
Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Novo Nordisk announced plans to invest $556 million to expand its Tianjin production facility. BeiGene was approved to market a new drug in the US.
Seeking Alpha · 03/24 11:15
Weekly Report: what happened at MKKGY last week (0311-0315)?
Weekly Report · 03/18 12:32
Merck KGaA: Moving To A Hold As 2025 Targets Are Now Doubtful
Merck KGaA's 2023 results were disappointing, with decreased revenue and EBITDA due to challenges in the Process Solutions and Semiconductor Solutions divisions. The company's net income and EPS also decreased in 2023. Merck's cash flows remained strong, but the company's 2024 guidance suggests continued FX headwinds. The German company had a plan to generate 25B EUR in revenue by 2025.
Seeking Alpha · 03/14 14:30
More
About MKKGY
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Performance Materials business provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Webull offers Merck KGaA stock information, including OTCPK: MKKGY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MKKGY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MKKGY stock methods without spending real money on the virtual paper trading platform.